CRYAA

CRYAA

Target · Small heat shock protein

CRYAA Alpha-crystallin A chain · crystallin alpha A

CRYAA (crystallin alpha A, also known as HSPB4 or CRYA1) is the alpha-A subunit of the alpha-crystallins, small heat shock proteins that contribute to lens transparency and refractive index. It also acts as a molecular chaperone, limiting protein aggregation under stress. Browse Assay Genie's current range of CRYAA research reagents below, or read on for the biology behind the target.

Cytoplasm and nucleusSmall heat shock proteinLinked to congenital cataract
173 aa
Protein length
~20 kDa
Molecular weight
21q22.3
Gene locus
HSP20 family
Protein family
Target information

What is CRYAA (crystallin alpha A)?

CRYAA, the alpha-A chain of alpha-crystallin, contributes to the transparency and refractive index of the lens. In its oxidised form, meaning without the intramolecular disulphide bond, it acts as a chaperone and prevents aggregation of a wide range of proteins under many stress conditions. It is also required for the correct formation of lens intermediate filaments, as part of a complex containing BFSP1, BFSP2 and CRYAA.

Mammalian lens crystallins fall into alpha, beta and gamma families. The alpha crystallins are built from two gene products, alpha-A and alpha-B (acidic and basic), and belong to the small heat shock protein (HSP20) family; they can be induced by heat shock. Their chaperone action differs from that of a classical chaperone: they do not renature proteins or release them, but hold them in large soluble aggregates. These heterogeneous assemblies contain 30-40 subunits, with alpha-A and alpha-B present in a 3:1 ratio. Post-translational modifications reduce chaperone ability. The two subunits are expressed differently: alpha-A is preferentially restricted to the lens, whereas alpha-B is expressed widely across tissues and organs.

Beyond chaperoning, alpha crystallins have an autokinase activity and take part in intracellular architecture. On the basis of these mechanistically distinct functions, the CRYAA protein has been identified as a moonlighting protein. The CRYAA gene is also known as HSPB4 and CRYA1, and defects in it cause autosomal dominant congenital cataract (ADCC). Mouse and rat orthologs are both named Cryaa.

Cataract research

Defects in the CRYAA gene cause autosomal dominant congenital cataract, making it a central target for studying lens opacity.

Lens biology

CRYAA contributes to lens transparency and refractive index, and is preferentially restricted to the lens.

Chaperone and proteostasis studies

As a small heat shock protein, CRYAA holds stressed proteins in soluble aggregates, preventing their aggregation.

Cytoskeleton and filament assembly

CRYAA is required for correct lens intermediate filament formation, in a complex with BFSP1 and BFSP2.

Background

CRYAA frequently asked questions

What does CRYAA do?

CRYAA contributes to the transparency and refractive index of the lens. In its oxidised form it acts as a chaperone, preventing protein aggregation under varied stress conditions. It is also required for correct lens intermediate filament formation, together with BFSP1 and BFSP2.

What are the other names for CRYAA?

CRYAA is also called HSPB4 and CRYA1, and its previous HGNC name was crystallin, alpha A. The protein is the alpha-crystallin A chain. It is one of two alpha-crystallin gene products, the other being the basic alpha-B subunit.

Is CRYAA linked to disease and found in other species?

Defects in the CRYAA gene cause autosomal dominant congenital cataract. Mouse and rat both have a Cryaa ortholog. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other crystallins, lens intermediate filament proteins and small heat shock proteins with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P02489; product specifications from Assay Genie datasheets.

CRYAA Product listing